NCT00710970 2022-01-24
Tamoxifen for Progressive Transitional Cell Carcinoma Following Previous Chemotherapy Treatment
Baylor College of Medicine
Phase 2 Completed
Clinical Trials
4 trialsNCT03147196 2019-01-22
Bicalutamide and Raloxifene Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery
Mayo Clinic
Phase 2 Withdrawn
NCT00019500 2013-06-20
Raloxifene in Preventing Breast Cancer in Premenopausal Women
National Cancer Institute (NCI)
Phase 2 Completed
NCT00004915 2012-06-06
Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer
Northwestern University
Phase 2 Completed